Literature DB >> 8650165

Stimulation of new bone formation by direct transfer of osteogenic plasmid genes.

J Fang1, Y Y Zhu, E Smiley, J Bonadio, J P Rouleau, S A Goldstein, L K McCauley, B L Davidson, B J Roessler.   

Abstract

Degradable matrices containing expression plasmid DNA [gene-activated matrices (GAMs)] were implanted into segmental gaps created in the adult rat femur. Implantation of GAMs containing beta-galactosidase or luciferase plasmids led to DNA uptake and functional enzyme expression by repair cells (granulation tissue) growing into the gap. Implantation of a GAM containing either a bone morphogenetic protein-4 plasmid or a plasmid coding for a fragment of parathyroid hormone (amino acids 1-34) resulted in a biological response of new bone filling the gap. Finally, implantation of a two-plasmid GAM encoding bone morphogenetic protein-4 and the parathyroid hormone fragment, which act synergistically in vitro, caused new bone to form faster than with either factor alone. These studies demonstrate for the first time that repair cells (fibroblasts) in bone can be genetically manipulated in vivo. While serving as a useful tool to study the biology of repair fibroblasts and the wound healing response, the GAM technology may also have wide therapeutic utility.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8650165      PMCID: PMC39133          DOI: 10.1073/pnas.93.12.5753

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

Review 1.  The bone morphogenetic protein family and osteogenesis.

Authors:  J M Wozney
Journal:  Mol Reprod Dev       Date:  1992-06       Impact factor: 2.609

2.  Expression and localization of two low molecular weight GTP-binding proteins, Rab8 and Rab10, by epitope tag.

Authors:  Y T Chen; C Holcomb; H P Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

3.  Aggrecan core protein is expressed in membranous bone of the chick embryo. Molecular and biomechanical studies of normal and nanomelia embryos.

Authors:  M Wong; T Lawton; P F Goetinck; J L Kuhn; S A Goldstein; J Bonadio
Journal:  J Biol Chem       Date:  1992-03-15       Impact factor: 5.157

4.  Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro.

Authors:  T K Sampath; J C Maliakal; P V Hauschka; W K Jones; H Sasak; R F Tucker; K H White; J E Coughlin; M M Tucker; R H Pang
Journal:  J Biol Chem       Date:  1992-10-05       Impact factor: 5.157

5.  A pharmacological comparison of parathyroid hormone receptors in human bone and kidney.

Authors:  J J Orloff; A E Ribaudo; R L McKee; M Rosenblatt; A F Stewart
Journal:  Endocrinology       Date:  1992-10       Impact factor: 4.736

6.  Somatic gene transfer in the development of an animal model for primary hyperparathyroidism.

Authors:  J M Wilson; M Grossman; A R Thompson; C Lupassikis; A Rosenberg; J T Potts; H M Kronenberg; R C Mulligan; S R Nussbaum
Journal:  Endocrinology       Date:  1992-05       Impact factor: 4.736

7.  Patterns of expression of murine Vgr-1 and BMP-2a RNA suggest that transforming growth factor-beta-like genes coordinately regulate aspects of embryonic development.

Authors:  K M Lyons; R W Pelton; B L Hogan
Journal:  Genes Dev       Date:  1989-11       Impact factor: 11.361

8.  Involvement of Bone Morphogenetic Protein-4 (BMP-4) and Vgr-1 in morphogenesis and neurogenesis in the mouse.

Authors:  C M Jones; K M Lyons; B L Hogan
Journal:  Development       Date:  1991-02       Impact factor: 6.868

9.  OP-1 cDNA encodes an osteogenic protein in the TGF-beta family.

Authors:  E Ozkaynak; D C Rueger; E A Drier; C Corbett; R J Ridge; T K Sampath; H Oppermann
Journal:  EMBO J       Date:  1990-07       Impact factor: 11.598

10.  Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro.

Authors:  A Yamaguchi; T Katagiri; T Ikeda; J M Wozney; V Rosen; E A Wang; A J Kahn; T Suda; S Yoshiki
Journal:  J Cell Biol       Date:  1991-05       Impact factor: 10.539

View more
  72 in total

1.  Platelet-derived growth factor (PDGF) gene delivery for application in periodontal tissue engineering.

Authors:  W V Giannobile; C S Lee; M P Tomala; K M Tejeda; Z Zhu
Journal:  J Periodontol       Date:  2001-06       Impact factor: 6.993

2.  Balancing cell migration with matrix degradation enhances gene delivery to cells cultured three-dimensionally within hydrogels.

Authors:  Jaclyn A Shepard; Alyssa Huang; Ariella Shikanov; Lonnie D Shea
Journal:  J Control Release       Date:  2010-05-05       Impact factor: 9.776

Review 3.  Strategies for controlled delivery of growth factors and cells for bone regeneration.

Authors:  Tiffany N Vo; F Kurtis Kasper; Antonios G Mikos
Journal:  Adv Drug Deliv Rev       Date:  2012-02-04       Impact factor: 15.470

4.  Cellular transduction gradients via vapor-deposited polymer coatings.

Authors:  Yaseen M Elkasabi; Joerg Lahann; Paul H Krebsbach
Journal:  Biomaterials       Date:  2010-12-22       Impact factor: 12.479

5.  Plasmid delivery in vivo from porous tissue-engineering scaffolds: transgene expression and cellular transfection.

Authors:  Jae-Hyung Jang; Christopher B Rives; Lonnie D Shea
Journal:  Mol Ther       Date:  2005-09       Impact factor: 11.454

Review 6.  Current concepts in periodontal bioengineering.

Authors:  M Taba; Q Jin; J V Sugai; W V Giannobile
Journal:  Orthod Craniofac Res       Date:  2005-11       Impact factor: 1.826

7.  Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4.

Authors:  Hairong Peng; Vonda Wright; Arvydas Usas; Brian Gearhart; Hsain-Chung Shen; James Cummins; Johnny Huard
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

8.  Effect of sustained gene delivery of platelet-derived growth factor or its antagonist (PDGF-1308) on tissue-engineered cementum.

Authors:  Orasa Anusaksathien; Qiming Jin; Ming Zhao; Martha J Somerman; William V Giannobile
Journal:  J Periodontol       Date:  2004-03       Impact factor: 6.993

9.  Regulated non-viral gene delivery from coaxial electrospun fiber mesh scaffolds.

Authors:  Anita Saraf; L Scott Baggett; Robert M Raphael; F Kurtis Kasper; Antonios G Mikos
Journal:  J Control Release       Date:  2009-12-16       Impact factor: 9.776

10.  Non-viral gene-activated matrices: next generation constructs for bone repair.

Authors:  Erica G Tierney; Garry P Duffy; Sally-Ann Cryan; Caroline M Curtin; Fergal J O'Brien
Journal:  Organogenesis       Date:  2013-01-01       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.